Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
12/01/2022* -- Results Q3 2023 -- 1.07 --
12/01/2022* 17:00 EST Earnings Call Q3 2023 -- -- --
08/31/2022 -- Results Q2 2023 1.03 1.01 1.95%
08/31/2022 17:00 EST Earnings Call Q2 2023 -- -- --
06/01/2022 -- Results Q1 2023 0.99 0.92 7.34%
06/01/2022 17:00 EST Earnings Call Q1 2023 -- -- --
03/02/2022 -- Results Q4 2022 0.90 0.88 1.97%
03/02/2022 17:00 EST Earnings Call Q4 2022 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 12/01/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 08/31/2022
Beat/Miss Upgrade
Return Since -20.74%
Last FQE 07/31/2022
Next FQE 10/31/2022

Profile

Edit
Veeva is a leading supplier of software solutions for the life sciences industry. The company’s best-of-breed offering addresses operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise and cloud-based platform to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. As the vertical leader, Veeva innovates, increases wallet share at existing customers, and expands into other industries with similar regulations, protocols, and procedures, such as consumer goods, chemicals, and cosmetics.
URL https://www.veeva.com
Investor Relations URL https://ir.veeva.com/investors/investor-overview/default.aspx
HQ State/Province California
Sector Healthcare
Industry Health Information Services
Equity Style Mid Cap/Growth
Next Earnings Release Dec. 01, 2022 (est.)
Last Earnings Release Aug. 31, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
9.24%
41.07%
35.82%
61.58%
57.48%
93.55%
-6.16%
-38.16%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-22.42%
52.72%
-0.40%
69.50%
25.25%
47.44%
148.6%
-33.94%
1.33%
--
--
--
--
--
--
-59.75%
-2.62%
--
--
--
--
--
--
-56.01%
-31.24%
-97.00%
-95.08%
1.69%
-50.00%
0.00%
166.7%
425.0%
-66.67%
As of September 26, 2022.

Profile

Edit
Veeva is a leading supplier of software solutions for the life sciences industry. The company’s best-of-breed offering addresses operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise and cloud-based platform to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. As the vertical leader, Veeva innovates, increases wallet share at existing customers, and expands into other industries with similar regulations, protocols, and procedures, such as consumer goods, chemicals, and cosmetics.
URL https://www.veeva.com
Investor Relations URL https://ir.veeva.com/investors/investor-overview/default.aspx
HQ State/Province California
Sector Healthcare
Industry Health Information Services
Equity Style Mid Cap/Growth
Next Earnings Release Dec. 01, 2022 (est.)
Last Earnings Release Aug. 31, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
TRUZX 1.241B USD 5.39%
APDMX 216.88M USD 4.78%
CMGSX 471.36M USD 2.75%
MOAT 145.59M USD 2.44%
FDN 85.92M USD 2.29%
ABPRX 282.72M USD 1.65%
ARKG 36.75M USD 1.59%
RRMGX 370.93M USD 1.35%
VOT 187.59M USD 0.96%
IMCG 7.126M USD 0.64%
VEXMX 378.46M USD 0.45%
VXF 378.46M USD 0.45%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter VEEV Tweets